Ophthalmology, Retina Specialist · El Paso, TX
NPI
1568786176
Since 2010
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1700 Curie Dr Ste 3800
El Paso, TX, 79902
Phone (915) 532-3912
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
25,301 services
Medicare patients, 2024
707
Average age 77
Drug cost, 2024
$21K
544 prescriptions
Company payments, 2025
$1,205
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Kasuga was code J2777 (injection, faricimab-svoa, 0.1 mg), 7,680 times for 22 patients. In total Daniel Kasuga billed 25,301 services in 36 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 7,680 | 22 | $27.33 | $210K |
| Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 5,415 | 201 | $177.09 | $959K |
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2,625 | 35 | $116.74 | $306K |
| 92250 Angiography | Office | 2,193 | 678 | $28.79 | $63K |
| 92014 Ophthalmological E&M | Office | 2,018 | 608 | $98.20 | $198K |
| 67028 Intravitreal Injection | Office | 1,645 | 371 | $109.78 | $181K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 857 | 37 | $124.06 | $106K |
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 840 | 13 | $86.58 | $73K |
| J0178 Injection, aflibercept, 1 mg | Office | 836 | 77 | $638.77 | $534K |
| 92235 Angiography | Office | 238 | 225 | $116.48 | $28K |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 203 | 12 | $154.37 | $31K |
| 99204 Office E&M - New | Office | 151 | 151 | $113.29 | $17K |
| J7999 Compounded drug, not otherwise classified | Office | 101 | 46 | $81.16 | $8,197 |
| 92134 Computerized Ophthalmic Imaging | Office | 87 | 86 | $30.07 | $2,616 |
| 76512 Ultrasound - Nonspecific | Office | 23 | 20 | $38.42 | $884 |
By year: 2022 $2.6M for 11,655 services; 2023 $2.9M for 20,173 services; 2024 $2.8M for 25,301 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Kasuga prescribed most often to Medicare patients was Prednisolone Acetate, with 204 prescriptions and refills. In total Daniel Kasuga wrote 544 Medicare prescriptions that cost $21K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 204 | 247 | 137 | $7,027 |
| Moxifloxacin Moxifloxacin Hcl | 129 | 129 | 111 | $3,977 |
| Brimonidine Tartrate Generic | 51 | 77 | 26 | $243 |
| Cyclopentolate Hcl Generic | 49 | 76 | 46 | $785 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 38 | 109 | 25 | $525 |
| Latanoprost Generic | 21 | 24 | Under 11 | $69.22 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 14 | 17 | Under 11 | $1,694 |
Brand drugs: 226 claims; generic drugs: 318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Kasuga $1,205 ($1,205 in general payments such as food, travel and fees) from 9 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $231.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 2 | $231 |
| Alcon Vision LLC ALC | 2 | $221 |
| Amgen Inc. AMGN | 2 | $196 |
| Astellas Pharma US Inc 4503.T | 2 | $146 |
| Genentech USA, Inc. ROG.SW | 3 | $141 |
| Harrow Eye, LLC | 2 | $111 |
| Sandoz Inc. SDZ.SW | 1 | $74.04 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $60.99 |
| Apellis Pharmaceuticals, Inc. APLS | 1 | $24.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.